A detailed history of Advisor Group Holdings, Inc. transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 931,833 shares of CTXR stock, worth $2.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
931,833
Previous 932,333 0.05%
Holding current value
$2.41 Million
Previous $540,000 13.89%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$0.48 - $1.02 $240 - $510
-500 Reduced 0.05%
931,833 $465,000
Q1 2024

May 10, 2024

BUY
$0.6 - $0.9 $48 - $72
80 Added 0.01%
932,333 $839,000
Q4 2023

Feb 12, 2024

BUY
$0.65 - $0.86 $558,900 - $739,468
859,847 Added 1187.54%
932,253 $708,000
Q3 2023

Nov 13, 2023

BUY
$0.65 - $1.25 $20,606 - $39,628
31,703 Added 77.89%
72,406 $49,000
Q2 2023

Aug 10, 2023

BUY
$1.08 - $1.65 $1,137 - $1,737
1,053 Added 2.66%
40,703 $48,000
Q1 2023

May 12, 2023

SELL
$0.78 - $1.42 $4,680 - $8,520
-6,000 Reduced 13.14%
39,650 $46,000
Q4 2022

Feb 10, 2023

BUY
$0.79 - $1.28 $7,110 - $11,520
9,000 Added 24.56%
45,650 $36,000
Q3 2022

Nov 14, 2022

BUY
$0.14 - $1.33 $280 - $2,660
2,000 Added 5.77%
36,650 $44,000
Q1 2022

May 04, 2022

SELL
$1.38 - $1.89 $4,140 - $5,670
-3,000 Reduced 7.97%
34,650 $62,000
Q3 2021

Nov 05, 2021

SELL
$1.74 - $2.6 $4,959 - $7,410
-2,850 Reduced 7.04%
37,650 $76,000
Q2 2021

Aug 02, 2021

SELL
$1.51 - $4.23 $50,585 - $141,705
-33,500 Reduced 45.27%
40,500 $141,000
Q1 2021

May 13, 2021

BUY
$1.04 - $2.34 $22,360 - $50,310
21,500 Added 40.95%
74,000 $131,000
Q4 2020

Feb 10, 2021

BUY
$0.9 - $1.2 $42,750 - $57,000
47,500 Added 950.0%
52,500 $54,000
Q3 2020

Nov 12, 2020

BUY
$0.83 - $1.51 $4,150 - $7,550
5,000 New
5,000 $5,000
Q2 2020

Aug 14, 2020

SELL
$0.65 - $1.45 $650 - $1,450
-1,000 Closed
0 $0
Q1 2020

May 18, 2020

BUY
$0.46 - $1.3 $460 - $1,300
1,000 New
1,000 $1,000

Others Institutions Holding CTXR

About Citius Pharmaceuticals, Inc.


  • Ticker CTXR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 146,130,000
  • Market Cap $378M
  • Description
  • Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...
More about CTXR
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.